Is Pharmacologic Prophylaxis for Venous Thromboembolism Necessary in People With Hemophilia After Total Knee and Hip Arthroplasty?

Document Type : CURRENT CONCEPTS REVIEW

Authors

1 Department of Orthopaedic Surgery, La Paz University Hospital, Madrid, Spain

2 Department of Physical Medicine and Rehabilitation; La Paz University Hospital, Madrid, Spain

3 Faculty of Health, Education and Society, University of Northampton, Northampton, UK and the County Clinic, UK

10.22038/abjs.2025.88708.4023

Abstract

Pharmacologic thromboprophylaxis for postoperative venous thromboembolism (VTE) after total knee arthroplasty (TKA) and total hip arthroplasty (THA) in people with hemophilia (PWH) is highly controversial. In PWH the prevalence of symptomatic VTE after TKA and THA is between 0 to 5%, while the prevalence of asymptomatic VTE is between 7.5% and 10%. In PWH many clinicians have not used pharmacologic thromboprophylaxis. Others have used low molecular weight heparin (LMWH) and reduced doses of DOAC [direct oral anticoagulants (thrombin inhibitors and Factor Xa inhibitors)]. It appears that pharmacologic thromboprophylaxis should only be carried out in PWH undergoing TKA and THA who have VTE risk factors [e.g., old age, prior VTE, varicose veins, general anesthesia, cancer, Factor V (Leiden) mutation, and obesity]. After TKA and THA in PWH, early mobilization is essential. Some authors have advocated additional mechanical thromboprophylaxis (pneumatic compression devices). In conclusion, for all PWH experiencing TKA and THA mechanical prophylaxis is sensible. Some form of pharmacologic prophylaxis should be strongly considered for PWH with clear risk factors. The main area of doubt is in PWH without risk factors. More prospective multicenter studies are required. Difficulties will be getting agreement on universal regimes to be followed; and the relatively small numbers of PWH experiencing TKA and THA.
        Level of evidence: III

Keywords

Main Subjects

References

  1. Solimeno LP, Mancuso ME, Pasta G, Santagostino E, Perfetto S, Mannucci PM. Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br J Haematol. 2009;145:227-234. doi: 10.1111/j.1365-2141.2009.07613.x.
  2. Carulli C, Rizzo AR, Innocenti M. Hip arthropathy in haemophilia. J Clin Med 2017;6:44. doi: 10.3390/jcm6040044.
  3. Pasta G, Vanelli R, Jannelli E, et al. Primary total knee replacement in hemophiliacs: experience of a single institution over fourteen years of surgical procedures. J Biol Regul Homeost Agents .2018;32(6 Suppl. 1):145-150.
  4. Mortazavi SJ, Bagheri N, Farhoud A, Hadi Kalantar S, Ghadimi E. Total knee arthroplasty in patients with hemophilia: what do we know? Arch Bone Jt Surg. 2020;8:470-478. doi: 10.22038/abjs.2019.42247.2149.
  5. Mortazavi SJ, Daneshpoor SMM, Shafiei SH. Total hip arthroplasty in patients with hemophilia: what do we know? Arch Bone Jt Surg. 2023;11:434-440. doi: 10.22038/ABJS.2023.58812.291.
  6. Carulli C, Innocenti M, Tambasco R, Perrone A, Civinini R. Total knee arthroplasty in haemophilia: long-term results and survival rate of a modern knee implant with an oxidized zirconium femoral component. J Clin Med. 2023;12:4356. doi: 10.3390/jcm1213435.
  7. Rodriguez-Merchan EC. Total hip arthroplasty in hemophilic patients: are their results similar to those of nonhemophilic patients? Arch Bone Jt Surg. 2024;12:357-360. doi: 10.22038/ABJS.2024.76984.3555.
  8. Rodriguez-Merchan. Primary total knee arthroplasty in hemophilia and allied disorders: revision rates and their causes. Arch Bone Jt Surg. 2024;12:428-432. doi: 10.22038/ABJS.2024.76697.3544.
  9. Valentino LA, Santaella ME, Carlson SA, Recht M. Contemporary approaches to treat people with hemophilia: what's new and what's not? Res Pract Thromb Haemost. 2025;9:102696. doi: 10.1016/j.rpth.2025.102696.
  10. Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: an unexpected association! Haemophilia. 2004;10:319-326. doi: 10.1111/j.1365-2516.2004.00906.x.
  11. Perez Botero J, Spoon DB, Patnaik MS, Ashrani AA, Trousdale RT, Pruthi RK. Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective study. Thromb Res. 2015;135:109-113. doi: 10.1016/j.thromres.2014.11.010.
  12. Siboni SM, Biguzzi E, Solimeno LP, et al. Orthopaedic surgery in patients with von Willebrand disease. Haemophilia. 2014;20:133-140. doi: 10.1111/hae.12258.
  13. Ono K, Takedani H. Risk of deep venous thrombosis after total knee arthroplasty in patients with haemophilia A. Haemophilia. 2020;26:867-872. doi: 10.1111/hae.14095.
  14. Santagata D, Abenante A, Squizzato A, et al. Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review. J Thromb Haemost. 2024;22:1117-1131. doi: 10.1016/j.jtha.2023.12.036.
  15. Rodriguez-Merchan EC. Pharmacological thromboprophylaxis in people with hemophilia experiencing orthopedic surgery: what does the literature say in 2023? J Clin Med. 2023;12:5574. doi: 10.3390/jcm12175574.
  16. Pan JF, Chu XB, Zhuang RJ, et al. [Clinical experience on postoperative balance of hemostasis and antithrombus for patients with hemophilic arthritis after arthroplasty]. Zhongguo Gu Shang. 2015;28(3):268-271.
  17. Hermans C, Lambert C, Gatteri VI, Passeri WA, Holme P, Martinelli M. Multicentric and international study evaluating clinical and subclinical venous thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Haemophilia; Wiley: Hoboken, NJ, USA. 2016;22:84.
  18. Buckner TW, Leavitt AD, Ragni M, et al. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost. 2016;116:42-49. doi: 10.1160/TH15-10-0802.
  19. Zhai J, Weng X, Lin J, Qian W, Guo S. Efficacy of a modified coagulation factor substitution for total hip arthroplasty in patients with end-stage haemophilic arthropathy. Blood Coagul Fibrinolysis. 2017;28:24-27. doi: 10.1097/MBC.0000000000000527.
  20. Peng HM, Wang LC, Zhai JL, et al. Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing hip and knee joint replacement without chemoprophylaxis: a retrospective study. Orthop Surg. 2019;11:236-240. doi: 10.1111/os.12444.
  21. Rosas S, Buller LT, Plate J, Higuera C, Barsoum WK, Emory C. Total knee arthroplasty among Medicare beneficiaries with hemophilia A and B is associated with increased complications and higher costs. J Knee Surg. 2021;34:372-377. doi: 10.1055/s-0039-1696691.
  22. Gillinov SM, Burroughs PJ, Moore HG, Rubin LE, Frumberg DB, Grauer JN. Total hip arthroplasty in patients with classic hemophilia: a matched comparison of 90-day outcomes and 5-year implant survival. J Arthroplasty. 2022;37:1333-1337. doi: 10.1016/j.arth.2022.02.107.
  23. Zhang Q, Zhao L, Riva N, et al. Incidence of deep venous thrombosis in patients with hemophilia undergoing bilateral simultaneous total knee arthroplasty: a retrospective cohort study. BMC Musculoskelet Disord. 2024;25:326. doi: 10.1186/s12891-024-07404-2.
  24. Dindo D, Breitenstein S, Hahnloser D, et al. Kinetics of D-dimer after general surgery. Blood Coagul Fibrinolysis. 2009;20:347-52. doi: 10.1097/MBC.0b013e32832a5fe6.
  25. Ahmed A, Kozek-Langenecker S, Mullier F, Pavord S, Hermans C. European guidelines on perioperative venous thromboembolism prophylaxis: patients with preexisting coagulation disorders and after severe perioperative bleeding. Eur J Anaesthesiol. 2018;35:96-107. doi: 10.1097/EJA.0000000000000725.
  26. Tripodi A, Mannucci PM, Peyvandi F. Hemophilia patients: are they naturally anticoagulated? Intern Emerg Med. 2023;18:1251-1254. doi: 10.1007/s11739-023-03331-7.
  27. Kleiboer B, Layer MA, Cafuir LA, et al. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study. J Thromb Haemost. 2022;20:857-865. doi: 10.1111/jth.15654.
  28. Schutgens REG, Jimenez-Yuste V, Escobar M, et al. Antithrombotic treatment in patients with hemophilia: an EHA-ISTH-EAHAD-ESO clinical practice guidance. HemaSphere. 2023;7:e900. doi: 10.1097/HS9.0000000000000900.

 

 

 

 

 

The Archives of Bone and Joint Surgery
Volume 14, Issue 2
February 2026
Pages 98-103

Files

History

  • Receive Date: 02 June 2025
  • Revise Date: 31 January 2026
  • Accept Date: 23 June 2025

Share

How to cite

Statistics